R-405 replicated in LNCaP and 22Rv1 cells, strengthening the notion that R-405 successfully targeted PSMA-positive human prostate cancer cells; R-405 also replicated in PC3-PIP cells. Here, FOLH1 is linked to prostate carcinoma.